Observ Prosp Study of Acalabrutinib in CLL Therapy in Real Clinical Practice in Belarus

NCT07288515 · clinicaltrials.gov ↗
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

AstraZeneca